Fluvastatin is a member of the statin class of medications used to lower cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, and reduce the risk of cardiovascular diseases such as heart attack and stroke. It works by inhibiting the enzyme HMG-CoA reductase, a key regulator in cholesterol synthesis in the liver. Fluvastatin was developed in the late 1980s and became one of the earlier fully synthetic statins, later marketed by Novartis under brand names like Lescol. It gained approval for clinical use in the 1990s and has since been used for managing hyperlipidemia, often as part of long-term preventive therapy alongside lifestyle modifications.
BRAND NAMES
Fluvastatin is a statin medication most commonly marketed under the brand names Lescol and Lescol XL (extended-release). It is prescribed to manage high cholesterol and triglyceride levels and to lower the risk of heart attacks and strokes. Fluvastatin is also available in generic form.
MECHANISM OF ACTION
Fluvastatin is a synthetic HMG-CoA reductase inhibitor, or statin, that lowers cholesterol production in the liver by competitively blocking the HMG-CoA reductase enzyme, which normally converts HMG-CoA to mevalonate. This reduction in hepatic cholesterol stimulates an increase in LDL receptors, helping to remove LDL cholesterol from the bloodstream.
PHARMACOKINETICS
Absorption: Fluvastatin is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 0.5–2 hours. Its bioavailability is moderate due to first-pass metabolism in the liver.
Distribution: The drug is highly protein-bound in plasma (approximately 98%) and distributes extensively throughout body tissues.
Metabolism: Fluvastatin is primarily metabolized in the liver via the CYP2C9 enzyme into inactive metabolites.
Elimination: The majority of fluvastatin and its metabolites are excreted in the bile and feces, with less than 6% eliminated through urine.
PHARMACODYNAMICS
Fluvastatin is a synthetic, lipophilic HMG-CoA reductase inhibitor that competitively and reversibly blocks the liver enzyme responsible for converting HMG-CoA to mevalonate, the rate-limiting step in cholesterol production. This action lowers LDL cholesterol and total cholesterol levels while stimulating the liver to produce more LDL receptors, enhancing the clearance of LDL from the bloodstream.
ADMINISTRATION
Fluvastatin is an oral statin (HMG-CoA reductase inhibitor) used to lower high cholesterol, with typical daily doses ranging from 20 to 80 mg. Immediate-release capsules are generally taken once in the evening, while extended-release (XL) tablets can be taken at any time of day. The tablets or capsules should be swallowed whole, with or without food.
DOSAGE AND STRENGTH
Fluvastatin is usually prescribed for adults at doses ranging from 20 to 80 mg once daily, depending on cholesterol levels and cardiovascular risk. Immediate-release capsules are typically taken in the evening, while extended-release (XL) tablets allow for once-daily dosing at any time of day. The medication should be swallowed whole and can be taken with or without food.
DRUG INTERACTIONS
Fluvastatin interacts significantly with medications that inhibit CYP2C9, including fluconazole, gemfibrozil, and cyclosporine, which can raise fluvastatin levels and increase the risk of side effects such as rhabdomyolysis. Other important interactions include warfarin, which may elevate bleeding risk, and certain immunosuppressants. Limiting alcohol intake is also recommended to reduce the risk of liver damage.
FOOD INTERACTIONS
Fluvastatin (Lescol) can be taken with or without food, although food may slightly delay its absorption. The main dietary consideration is to avoid grapefruit and grapefruit juice, as they can increase the risk of side effects. Alcohol intake should also be limited to reduce the risk of liver toxicity.
CONTRAINDICATIONS
Fluvastatin is contraindicated in individuals with a known hypersensitivity to any ingredient in the medication, active liver disease, or unexplained persistent elevations in serum transaminases. It should not be used during pregnancy, in women who may become pregnant, or while breastfeeding, due to the risk of harm to the fetus or nursing infant.
SIDE EFFECTS
Fluvastatin, a cholesterol-lowering statin, commonly produces side effects such as headache, nausea, diarrhea, abdominal discomfort, muscle pain (myalgia), and difficulty sleeping. Although it is effective and generally safe, it can rarely lead to serious conditions like rhabdomyolysis (muscle breakdown) or liver injury. Careful use is recommended in individuals with existing liver or kidney disease.
OVER DOSE
An overdose of Fluvastatin (Lescol) is a medical emergency that requires immediate attention or contacting a poison control center. There is no specific antidote, so management is mainly supportive. Symptoms of overdose may include severe muscle pain or breakdown (rhabdomyolysis), kidney failure, elevated liver enzymes, and nausea or vomiting.
TOXICITY
Fluvastatin is generally well tolerated, but it may cause notable toxic effects, particularly muscle-related toxicity (such as muscle pain and rhabdomyolysis) and liver toxicity (including elevated liver enzymes and jaundice). Although serious adverse reactions are uncommon, they can include acute kidney injury and liver damage. The drug may also cause gastrointestinal discomfort and is known to have potential drug interactions, especially with fibrates.
